Nello Mainolfi Kymera Therapeutics, Inc. (KYMR) insider trading activity

KYMR Quotes by TradingView

Nello Mainolfi is Chief Executive Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 649,959 shares of KYMR, which is worth approximately $28.3 Million. The most recent transaction as insider was on Jul 01, 2024, when has been sold 18,773 shares (Common Stock) at a price of $5.33 per share, resulting in proceeds of $100,060. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 650K
5.59% 3M change
13.29% 12M change
Total Value Held $28.3 Million

Nello Mainolfi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2024
BUY
Exercise of conversion of derivative security
$100,060 $5.33 p/Share
18,773 Added 2.81%
649,959 Common Stock
Jun 18 2024
BUY
Exercise of conversion of derivative security
$29,979 $2.08 p/Share
14,413 Added 2.23%
631,186 Common Stock
Jan 02 2024
BUY
Exercise of conversion of derivative security
$18,720 $2.08 p/Share
9,000 Added 1.44%
615,570 Common Stock
Nov 03 2023
BUY
Exercise of conversion of derivative security
$41,600 $2.08 p/Share
20,000 Added 3.19%
606,570 Common Stock
Aug 08 2023
BUY
Exercise of conversion of derivative security
$24,960 $2.08 p/Share
12,000 Added 2.0%
586,570 Common Stock
Dec 08 2022
BUY
Exercise of conversion of derivative security
$20,800 $2.08 p/Share
10,000 Added 1.71%
573,700 Common Stock
Oct 17 2022
BUY
Exercise of conversion of derivative security
$124,243 $2.08 p/Share
59,732 Added 9.61%
561,931 Common Stock
May 03 2022
BUY
Exercise of conversion of derivative security
$41,600 $2.08 p/Share
20,000 Added 3.83%
502,199 Common Stock
Jan 14 2022
BUY
Exercise of conversion of derivative security
$20,800 $2.08 p/Share
10,000 Added 2.03%
482,199 Common Stock
Jan 12 2022
SELL
Open market or private sale
$453,336 $52.64 p/Share
8,612 Reduced 1.79%
472,199 Common Stock
Jan 12 2022
BUY
Exercise of conversion of derivative security
$17,913 $2.08 p/Share
8,612 Added 1.76%
480,811 Common Stock
Jan 11 2022
SELL
Open market or private sale
$920,273 $54.38 p/Share
16,923 Reduced 3.46%
472,199 Common Stock
Jan 11 2022
BUY
Exercise of conversion of derivative security
$35,200 $2.08 p/Share
16,923 Added 3.34%
489,122 Common Stock
Jan 10 2022
SELL
Open market or private sale
$1,208,617 $53.8 p/Share
22,465 Reduced 4.54%
472,199 Common Stock
Jan 10 2022
BUY
Exercise of conversion of derivative security
$46,727 $2.08 p/Share
22,465 Added 4.34%
494,664 Common Stock
Dec 16 2021
BUY
Exercise of conversion of derivative security
$16,640 $2.08 p/Share
8,000 Added 1.67%
472,199 Common Stock
Oct 11 2021
SELL
Open market or private sale
$348,882 $54.04 p/Share
6,456 Reduced 1.37%
464,199 Common Stock
Oct 11 2021
BUY
Exercise of conversion of derivative security
$13,428 $2.08 p/Share
6,456 Added 1.35%
470,655 Common Stock
Oct 08 2021
SELL
Open market or private sale
$2,431,155 $58.52 p/Share
41,544 Reduced 8.21%
464,199 Common Stock
Oct 08 2021
BUY
Exercise of conversion of derivative security
$86,412 $2.08 p/Share
41,544 Added 7.59%
505,743 Common Stock
Aug 19 2021
BUY
Exercise of conversion of derivative security
$24,960 $2.08 p/Share
12,000 Added 2.52%
464,199 Common Stock
Aug 04 2021
SELL
Open market or private sale
$62,251 $60.03 p/Share
1,037 Reduced 0.23%
452,199 Common Stock
Aug 04 2021
BUY
Exercise of conversion of derivative security
$2,157 $2.08 p/Share
1,037 Added 0.23%
453,236 Common Stock
Aug 03 2021
SELL
Open market or private sale
$340,537 $60.07 p/Share
5,669 Reduced 1.24%
452,199 Common Stock
Aug 03 2021
BUY
Exercise of conversion of derivative security
$11,792 $2.08 p/Share
5,669 Added 1.22%
457,868 Common Stock
NM

Nello Mainolfi

Chief Executive Officer
Watertown, MA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KYMR